OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Curcumin attenuates Adriamycin-resistance of acute myeloid leukemia by inhibiting the lncRNA HOTAIR/miR-20a-5p/WT1 axis
Junmin Liu, Min Li, Wei Luo, et al.
Laboratory Investigation (2021) Vol. 101, Iss. 10, pp. 1308-1317
Open Access | Times Cited: 33
Junmin Liu, Min Li, Wei Luo, et al.
Laboratory Investigation (2021) Vol. 101, Iss. 10, pp. 1308-1317
Open Access | Times Cited: 33
Showing 1-25 of 33 citing articles:
The role of polyphenols in overcoming cancer drug resistance: a comprehensive review
Parisa Maleki Dana, Fatemeh Sadoughi, Zatollah Asemi, et al.
Cellular & Molecular Biology Letters (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 121
Parisa Maleki Dana, Fatemeh Sadoughi, Zatollah Asemi, et al.
Cellular & Molecular Biology Letters (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 121
Role of natural products in tumor therapy from basic research and clinical perspectives
Zhisen Wang, Zhengcheng Liu, Jiao Qu, et al.
Acta Materia Medica (2024) Vol. 3, Iss. 2
Open Access | Times Cited: 14
Zhisen Wang, Zhengcheng Liu, Jiao Qu, et al.
Acta Materia Medica (2024) Vol. 3, Iss. 2
Open Access | Times Cited: 14
Curcumin: An epigenetic regulator and its application in cancer
Tianqi Ming, Tao Qiu, Shun Tang, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 156, pp. 113956-113956
Closed Access | Times Cited: 65
Tianqi Ming, Tao Qiu, Shun Tang, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 156, pp. 113956-113956
Closed Access | Times Cited: 65
LncRNA-miRNA axis in tumor progression and therapy response: An emphasis on molecular interactions and therapeutic interventions
Maliheh Entezari, Afshin Taheriazam, Sima Orouei, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 154, pp. 113609-113609
Open Access | Times Cited: 52
Maliheh Entezari, Afshin Taheriazam, Sima Orouei, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 154, pp. 113609-113609
Open Access | Times Cited: 52
Using ncRNAs as Tools in Cancer Diagnosis and Treatment—The Way towards Personalized Medicine to Improve Patients’ Health
Roberto Piergentili, Giuseppe Basile, Cristina Nocella, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 9353-9353
Open Access | Times Cited: 49
Roberto Piergentili, Giuseppe Basile, Cristina Nocella, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 9353-9353
Open Access | Times Cited: 49
Unraveling the therapeutic potential of natural products in the prevention and treatment of leukemia
Harsh Goel, Rahul Kumar, Pranay Tanwar, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 160, pp. 114351-114351
Open Access | Times Cited: 21
Harsh Goel, Rahul Kumar, Pranay Tanwar, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 160, pp. 114351-114351
Open Access | Times Cited: 21
Natural products reverse cancer multidrug resistance
Jiayu Zou, Qilei Chen, Xiao-Ci Luo, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 8
Jiayu Zou, Qilei Chen, Xiao-Ci Luo, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 8
The tale of SOX2: Focusing on lncRNA regulation in cancer progression and therapy
Peng Huang, Feng Wen, YiShan Li, et al.
Life Sciences (2024) Vol. 344, pp. 122576-122576
Closed Access | Times Cited: 8
Peng Huang, Feng Wen, YiShan Li, et al.
Life Sciences (2024) Vol. 344, pp. 122576-122576
Closed Access | Times Cited: 8
Regulatory mechanism of miR-20a-5p expression in Cancer
Wei Huang, Xiaoyue Wu, Shuaixi Xiang, et al.
Cell Death Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 27
Wei Huang, Xiaoyue Wu, Shuaixi Xiang, et al.
Cell Death Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 27
Curcumin in treatment of hematological cancers: Promises and challenges
Maliheh Entezari, Armita Tayari, Mahshid Deldar Abad Paskeh, et al.
Journal of Traditional and Complementary Medicine (2024) Vol. 14, Iss. 2, pp. 121-134
Open Access | Times Cited: 5
Maliheh Entezari, Armita Tayari, Mahshid Deldar Abad Paskeh, et al.
Journal of Traditional and Complementary Medicine (2024) Vol. 14, Iss. 2, pp. 121-134
Open Access | Times Cited: 5
Research Progress on Natural Products That Regulate miRNAs in the Treatment of Osteosarcoma
Guodan Zeng, Xinyu Liu, H. Lv, et al.
Biology (2025) Vol. 14, Iss. 1, pp. 61-61
Open Access
Guodan Zeng, Xinyu Liu, H. Lv, et al.
Biology (2025) Vol. 14, Iss. 1, pp. 61-61
Open Access
Macrophages in graft-versus-host disease (GVHD): dual roles as therapeutic tools and targets
Atieh Raoufi, Hamed Soleimani Samarkhazan, S Nouri, et al.
Clinical and Experimental Medicine (2025) Vol. 25, Iss. 1
Open Access
Atieh Raoufi, Hamed Soleimani Samarkhazan, S Nouri, et al.
Clinical and Experimental Medicine (2025) Vol. 25, Iss. 1
Open Access
Research progress on the role of lncRNA–miRNA networks in regulating adipogenic and osteogenic differentiation of bone marrow mesenchymal stem cells in osteoporosis
Fangyu An, Xiaoxia Wang, Chunmei Wang, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 14
Fangyu An, Xiaoxia Wang, Chunmei Wang, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 14
The role of HOTAIR in the modulation of resistance to anticancer therapy
Monica Cantile, Valentina Belli, Giosuè Scognamiglio, et al.
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access | Times Cited: 3
Monica Cantile, Valentina Belli, Giosuè Scognamiglio, et al.
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access | Times Cited: 3
Regulation of main ncRNAs by polyphenols: A novel anticancer therapeutic approach
Liang Zhang, Qingzheng Kang, Mengxiao Kang, et al.
Phytomedicine (2023) Vol. 120, pp. 155072-155072
Open Access | Times Cited: 9
Liang Zhang, Qingzheng Kang, Mengxiao Kang, et al.
Phytomedicine (2023) Vol. 120, pp. 155072-155072
Open Access | Times Cited: 9
Anticancer properties and mechanisms of botanical derivatives
Sudharma Banerjee, Stella Nau, Steven N. Hochwald, et al.
Phytomedicine Plus (2022) Vol. 3, Iss. 1, pp. 100396-100396
Open Access | Times Cited: 15
Sudharma Banerjee, Stella Nau, Steven N. Hochwald, et al.
Phytomedicine Plus (2022) Vol. 3, Iss. 1, pp. 100396-100396
Open Access | Times Cited: 15
Insights into the involvement of long non-coding RNAs in doxorubicin resistance of cancer
Haibo Zhang, Yang Hu, Jun‐Li Deng, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 8
Haibo Zhang, Yang Hu, Jun‐Li Deng, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 8
Traditional Chinese medicine for acute myelocytic leukemia therapy: exploiting epigenetic targets
Xinlong Gao, Xu Zuo, Tianjiao Min, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
Xinlong Gao, Xu Zuo, Tianjiao Min, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
Decoding the Oncogenic Signals from the Long Non-Coding RNAs
Revathy Nadhan, Danny N. Dhanasekaran
Onco (2021) Vol. 1, Iss. 2, pp. 176-206
Open Access | Times Cited: 14
Revathy Nadhan, Danny N. Dhanasekaran
Onco (2021) Vol. 1, Iss. 2, pp. 176-206
Open Access | Times Cited: 14
Non-coding RNAs in leukemia drug resistance: new perspectives on molecular mechanisms and signaling pathways
Atefe Rahmati, Alireza Mafi, Omid Vakili, et al.
Annals of Hematology (2023) Vol. 103, Iss. 5, pp. 1455-1482
Closed Access | Times Cited: 5
Atefe Rahmati, Alireza Mafi, Omid Vakili, et al.
Annals of Hematology (2023) Vol. 103, Iss. 5, pp. 1455-1482
Closed Access | Times Cited: 5
Long non-coding RNAs (lncRNAs) in hepatocellular carcinoma progression: Biological functions and new therapeutic targets
Mehrdad Hashemi, Sepideh Mirzaei, Mohammad Arad Zandieh, et al.
Progress in Biophysics and Molecular Biology (2022) Vol. 177, pp. 207-228
Closed Access | Times Cited: 9
Mehrdad Hashemi, Sepideh Mirzaei, Mohammad Arad Zandieh, et al.
Progress in Biophysics and Molecular Biology (2022) Vol. 177, pp. 207-228
Closed Access | Times Cited: 9
Construction of an immune-related prognostic signature and lncRNA–miRNA–mRNA ceRNA network in acute myeloid leukemia
Ling Qin, Boya Li, Shijie Wang, et al.
Journal of Leukocyte Biology (2024) Vol. 116, Iss. 1, pp. 146-165
Open Access | Times Cited: 1
Ling Qin, Boya Li, Shijie Wang, et al.
Journal of Leukocyte Biology (2024) Vol. 116, Iss. 1, pp. 146-165
Open Access | Times Cited: 1
MiR-20a-5p facilitates cartilage repair in osteoarthritis via suppressing mitogen-activated protein kinase kinase kinase 2
Jiazhi Liu, Guo Tang, Wenjun Liu, et al.
Bioengineered (2022) Vol. 13, Iss. 5, pp. 13801-13814
Open Access | Times Cited: 8
Jiazhi Liu, Guo Tang, Wenjun Liu, et al.
Bioengineered (2022) Vol. 13, Iss. 5, pp. 13801-13814
Open Access | Times Cited: 8
Curcuminoids as Modulators of EMT in Invasive Cancers: A Review of Molecular Targets With the Contribution of Malignant Mesothelioma Studies
Daniel Pouliquen, Alice Boissard, Cécile Henry, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 7
Daniel Pouliquen, Alice Boissard, Cécile Henry, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 7
Effects of curcumin on 5-fluorouracil resistance of colon cancer cells through the PI3K/AKT/mTOR pathway via MACC1
Xuefeng Ma, Xu Sun, Rongdi Wang, et al.
European Journal of Integrative Medicine (2022) Vol. 56, pp. 102202-102202
Closed Access | Times Cited: 6
Xuefeng Ma, Xu Sun, Rongdi Wang, et al.
European Journal of Integrative Medicine (2022) Vol. 56, pp. 102202-102202
Closed Access | Times Cited: 6
